Abstract |
The programmed death-ligand 1 (PD-L1), by binding to PD-1 on the surface of immune cells, activates a major immune checkpoint pathway. Elevated expression of PD-L1 in tumor cells mediates tumor-induced T-cell exhaustion and immune suppression; therefore protect the survival of tumor cells. Although blockade of the PD-1/PD-L1 axis exhibits great potential in cancer treatment, mechanisms driving the up-regulation of PD-L1 in tumor cells remain not fully understood. Here we found that type Iγ phosphatidylinositol 4-phosphate ( PtdIns(4)P) 5-kinase (PIPKIγ) is required for PD-L1 expression in triple negative breast cancer cells. Depletion of PIPKIγ inhibits both intrinsic and induced PD-L1 expression. Results from further analyses suggest that PIPKIγ promotes the transcription of the PD-L1 gene by activating the NF-κB pathway in these cells. These results demonstrate that PIPKIγ-dependent expression of PD-L1 is likely important for the progression of triple negative breast cancer.
|
Authors | Junli Xue, Chunhua Chen, Manlong Qi, Yan Huang, Lin Wang, Yong Gao, Haidong Dong, Kun Ling |
Journal | Oncotarget
(Oncotarget)
Vol. 8
Issue 26
Pg. 42414-42427
(Jun 27 2017)
ISSN: 1949-2553 [Electronic] United States |
PMID | 28465490
(Publication Type: Journal Article)
|
Chemical References |
- B7-H1 Antigen
- CD274 protein, human
- NF-kappa B
- Phosphotransferases (Alcohol Group Acceptor)
- 1-phosphatidylinositol-4-phosphate 5-kinase
|
Topics |
- B7-H1 Antigen
(genetics)
- Cell Line, Tumor
- Disease Progression
- Enzyme Activation
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- NF-kappa B
(agonists, metabolism)
- Phosphorylation
- Phosphotransferases (Alcohol Group Acceptor)
(genetics, metabolism)
- Signal Transduction
- Transcription, Genetic
- Triple Negative Breast Neoplasms
(genetics, metabolism, pathology)
|